{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:45Z","timestamp":1761519045912,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.4158\/ep12286.or","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T21:03:25Z","timestamp":1358802205000},"page":"426-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preserved Proinsulin Production in Homozygous Protein Tyrosine Phosphatase Nonreceptor Type 22 C1858T Variant Type 1 Diabetes: A Possible Explanation for Absence of Overt Ketoacidosis Despite Omission of Exogenous Insulin"],"prefix":"10.1016","volume":"19","author":[{"given":"Devin W.","family":"Steenkamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Milunsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Sternthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP12286.OR_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00586459","article-title":"Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus","volume":"33","author":"Snorgaard","year":"1990","journal-title":"Diabetologia"},{"key":"10.4158\/EP12286.OR_bb0015","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic \u03b2-cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"10.4158\/EP12286.OR_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/dc11-1236","article-title":"Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay","volume":"35","author":"Wang","year":"2012","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12286.OR_bb0025","first-page":"A573","article-title":"Pro-insulin levels. are significantly increased both in type 1 and type 2 diabetes compared with normal subjects [Abstract]","volume":"55(Suppl 1)","author":"Ionescu-Tirgoviste","year":"2006","journal-title":"Diabetes"},{"key":"10.4158\/EP12286.OR_bb0030","first-page":"A423","article-title":"Plasma proinsulin levels in long standing diabetes: marker for dysfunctional beta cell regeneration? [Abstract]","volume":"56(Suppl 1)","author":"Ionescu-Tirgoviste","year":"2007","journal-title":"Diabetes"},{"key":"10.4158\/EP12286.OR_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI6438","article-title":"Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release","volume":"104","author":"Hostens","year":"1999","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12286.OR_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02629258","article-title":"Abnormal proinsulin\/C-peptide ratio in juvenile diabetes","volume":"19","author":"Ludvigsson","year":"1982","journal-title":"Acta Diabetol Lat"},{"key":"10.4158\/EP12286.OR_bb0045","doi-asserted-by":"crossref","first-page":"14703","DOI":"10.1074\/jbc.M111.323220","article-title":"Disruption of proprotein convertase 1\/3 (PC1\/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion","volume":"287","author":"Refaie","year":"2012","journal-title":"J Biol Chem"},{"key":"10.4158\/EP12286.OR_bb0050","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMra1106700","article-title":"Proprotein convertases in health and disease","volume":"365","author":"Artenstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.4158\/EP12286.OR_bb0055","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1073\/pnas.88.9.3564","article-title":"PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues","volume":"88","author":"Benjannet","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP12286.OR_bb0060","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.167.3920.998","article-title":"Proinsulin: metabolic effects in the human forearm","volume":"167","author":"Fineberg","year":"1970","journal-title":"Science"},{"key":"10.4158\/EP12286.OR_bb0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/endo-88-3-714","article-title":"Hypoglycemic activity and immunological half-life of porcine insulin and proinsulin in baboons and swine","volume":"88","author":"Stoll","year":"1971","journal-title":"Endocrinology"},{"key":"10.4158\/EP12286.OR_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI106258","article-title":"Studies on the biological activity of porcine proinsulin","volume":"49","author":"Lazarus","year":"1970","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12286.OR_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(93)90103-C","article-title":"The effects of subcutaneous human proinsulin on the production of 64\/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man","volume":"19","author":"Davis","year":"1993","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP12286.OR_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051105","article-title":"Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes","volume":"42","author":"Leslie","year":"1999","journal-title":"Diabetologia"},{"key":"10.4158\/EP12286.OR_bb0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/db06-0942","article-title":"PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits","volume":"56","author":"Chelala","year":"2007","journal-title":"Diabetes"},{"key":"10.4158\/EP12286.OR_bb0090","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/dc07-1158","article-title":"The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control","volume":"31","author":"Petrone","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12286.OR_bb0095","first-page":"12","article-title":"The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes","volume":"23","author":"Nielsen","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.4158\/EP12286.OR_bb0100","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/diabetes.54.3.906","article-title":"Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes","volume":"54","author":"Zheng","year":"2005","journal-title":"Diabetes"},{"key":"10.4158\/EP12286.OR_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/08820139.2012.664226","article-title":"Association of PTPN22 C1858T polymorphism and type 1 diabetes: a meta-analysis","volume":"41","author":"Peng","year":"2012","journal-title":"Immunol Invest"},{"key":"10.4158\/EP12286.OR_bb0110","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-006-0225-4","article-title":"Lymphoid tyrosine phosphatase (LYP\/PTPN22) Ard620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes","volume":"49","author":"Hermann","year":"2006","journal-title":"Diabetologia"},{"key":"10.4158\/EP12286.OR_bb0115","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ng1205-1300","article-title":"Gaining insight into PTPN22 and autoimmunity","volume":"37","author":"Gregerson","year":"2005","journal-title":"Nat Genet"},{"key":"10.4158\/EP12286.OR_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin Immunol"},{"key":"10.4158\/EP12286.OR_bb0125","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s00125-006-0308-2","article-title":"Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes","volume":"49","author":"Meier","year":"2006","journal-title":"Diabetologia"},{"key":"10.4158\/EP12286.OR_bb0130","first-page":"113","article-title":"Proinsulin, proamylin and the beta cell endoplasmic reticulum: the key for the pathogenesis of different diabetes phenotypes","volume":"2","author":"Ionescu-Tirgoviste","year":"2007","journal-title":"Proc Rom Acad Series B"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/243578864075T333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:55:26Z","timestamp":1761515726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20421445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1530891X20421445"],"URL":"https:\/\/doi.org\/10.4158\/ep12286.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preserved Proinsulin Production in Homozygous Protein Tyrosine Phosphatase Nonreceptor Type 22 C1858T Variant Type 1 Diabetes: A Possible Explanation for Absence of Overt Ketoacidosis Despite Omission of Exogenous Insulin","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12286.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}